#IDIBELLfellows: Romina Miranda / Marta Valle

07/10/2020 15:00-16:00

Room 205 – Nou aulari UB-Bellvitge
Microsoft Teams Meeting


#IDIBELLconnect: Novel clinical and translational research approaches to mesothelioma, an orphan tumor

Ernest Nadal

Group Leader at Bellvitge Biomedical Research Institute (IDIBELL), Clinical Research in Solid Tumors Group, Oncobell Program
Head of Section of Thoracic, Brain and Head and Neck Tumors, Catalan Institute of Oncology (ICO), Department of Medical Oncology
Associate Professor, University of Barcelona, Department of Clinical Sciences, Campus Bellvitge

09/10/2020 13:00-14:00

Microsoft Teams Meeting


Career Day 2020

21/10/2020 -

21-22 October 2020
This event is being held online


La recerca en temps de pandèmia

Dra. Maria Ángeles Domínguez
Dr. Xavier Solanich

21/10/2020 19:00-

VII Programa de excelencia en el abordaje del paciente con EM de alta actividad

Unitat EM HUB

22/10/2020 -

22-23 Octubre 2020

Sala d’actes Bellvitge University hospital 9.00h


#IDIBELLconnect: RANK a novel therapeutic target in breast cancer

Speaker Eva Gonzalez-Suarez

Transformation and Metastasis Group, Oncobell Program

06/11/2020 13:00-14:00

PhD Day 2020

12/11/2020 -

12-13 November 2020
this event is being held online


#IDIBELLconnect: Generation of protective immunity against infections by removing non-neutralizing/blocking antibodies

Rafael Máñez

Group Leader at the Bellvitge Biomedical Research Institute (IDIBELL), Innate Immunity and Pathology of the Critical Patient Group, Infectious disease and transplantation Program
Director of Intensive Care Department at Bellvitge University Hospital

20/11/2020 13:00-14:00

Microsoft Teams Meeting



Xerrades Sinergia

Òscar Martínez Tirado
Marta Barrachina
Gabriela Jiménez
Anna Veiga
Esteve Fernandez
Susana Jiménez
Rafael Máñez
Mònica Povedano
Miquel Àngel Pujana
Laia Alemany
Montse Nacher

28/11/2020 10:00-19:00

Online i en directe:
https://sinergia.l-h.cat/


#IDIBELLconnect: The mTOR-LARP1 axis and the anabolic reservoir of tumor cells: A new therapeutic target in colorectal cancer and beyond

Antonio Gentilella

Metabolism and Cancer Group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL)
Department of Physiology and Biochemistry, Faculty of Pharmacy, University of Barcelona

04/12/2020 13:00-14:00

Microsoft Teams Meeting


#IDIBELLconnect: Immunotherapeutic potential of oncolytic Vaccinia viruses

Juan Jose Rojas

Bellvitge Biomedical Research Institute (IDIBELL)
Unitat d’Immunologia, Departament de Patologia i Terapèutica Experimental, Universitat de Barcelona

18/12/2020 13:00-14:00

Microsoft Teams Meeting


Thesis: Caracterización de la actividad inmunomoduladora de C4BP(β-). Mecanismos moleculares y eficacia terapéutica en procesos inmunoinflamatorios

Thesis Lecture: Thursday June 23 10.00 sala de Graus UB – Campus Bellvitge Caracterización de la actividad…

Read More

Thesis: LIF as a metabolic messenger: study of glucose sensing by NSCLC and LIF‐mediated nutrient stress responses

Thesis lecture FRIDAY 17.06 | 11.00 | Aula de Graus – UB Bellvitge LIF as a metabolic…

Read More

Colorectal Cancer Risk Modeling and Genetic Epidemiology

Read More

Elles contra l’ELA

‘Elles contra l’ELA’ és una campanya de fundraising dirigida a recaptar fons per a la investigació de caràcter bàsic…

Read More

Oncobell 2nd International Symposium

We are pleased to invite you to participate in the 2nd International Symposium: Building bridges between science,…

Read More

15a Festa de la Ciència de Barcelona

Taller “I tu, t’arrisques? El joc de la prevenció“, a càrrec del grup d’Infeccions i Càncer de…

Read More

Presentation of NanoString technologies: nCounter and GeoMx® Digital Spatial Profiler

We will introduce you to NanoString! Learn how this technology extends its expression analysis capabilities to spatial…

Read More

Webinar: How to go green in a bioscience lab

All problems have a solution! Biomedical research is essential and thus we need to find a way…

Read More

Horizon Europe – Cluster 1 health information day (basic & epidemiological research)

We would like to inform you that IDIBELL, together with HUB, UB, and ICO Research Committee will…

Read More

Horizon Europe – Cluster 1 health information day (clinical research)

We would like to inform you that IDIBELL, together with HUB, UB, and ICO Research Committee will…

Read More